The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2024 | Challenges in distinguishing AL amyloidosis from ATTR amyloidosis
In this video, Olga Gursky, PhD, Boston University, Boston, MA, discusses challenges in diagnosing light chain (AL) amyloidosis versus transthyretin (ATTR) amyloidosis. Risky organ biopsies are often needed for accuracy, though noninvasive methods like radioactive tracer uptake can be used as an alternative. The role of calcification and amyloid fibril structures in diagnosis are also explored. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
